Infertility, Infertility, Female
Conditions
Brief summary
This study evaluate the percentage of women with thin endometrium who achieve an endometrial thickness equal to or greater than 7 mm after administration of PRGF (plasma rich in growth factors)
Interventions
Intrauterine administration of PRGF
Sponsors
Sara Rafael Fernandez
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No
Inclusion criteria
* Women who signed informed consent. * Women who understand the Spanish language. * Women under 42 years
Exclusion criteria
* Thrombopenia. * Congenital or acquired uterine malformations that reduce embryo implantation or term gestation. * Ovarian tumors. * Benign uterine tumors require surgical treatment * Local acute inflammatory diseases * Patients with malignant tumors requiring chemotherapy. * Patients with acute or chronic infectious or inflammatory diseases requiring active treatment with drugs that may interfere with implantation and gestation. * Chronic treatment with NSAIDs (Nonsteroidal anti-inflammatory drugs)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of women who achieve an endometrial thickness equal to or greater than 7 mm | 3 days after administration of PRGF | Measurement of the endometrial thickness by ultrasonography. |
Countries
Spain
Outcome results
None listed